IPROMOMED IPROMOMED

IPROMOMED

PRMD

Rank in Stocks #8323
Operating out of Russia, iPROMOMED functions as a pharmaceutical and... Operating out of Russia, iPROMOMED functions as a pharmaceutical and biotechnology enterprise dedicated to the research, production, and commercialization of both traditional prescription medications and cutting-edge therapeutic solutions.
Share Price
$5.11
Last synced: 2026-11-09
Market Cap
$1.09B
Change (1 day)
-0.29%
Change (1 year)
7.86%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
Operating Margin for IPROMOMED (PRMD)
Operating Margin as of November 2026 TTM: 36.26%
According to IPROMOMED's latest financial reports, its current operating margin (TTM) is 36.26%. At the end of 2025 the company had an operating margin of 36.52%.
Operating Margin history for IPROMOMED from 2025 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 36.26% -0.71%
2025 36.52% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
19.41% -99.46%
DE
19.68% -99.46%
DE
13.26% -99.63%
JP
17.08% -99.53%
CH
14.92% -99.59%
IL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about IPROMOMED's operating margin

What is IPROMOMED's operating margin?

IPROMOMED's operating margin is 36.26%, as of Nov 2026.

How does IPROMOMED's operating margin compare with similar companies?

IPROMOMED's operating margin (36.26%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.